Cross-cultural comparison of breast cancer patients’ Quality of Life in the Netherlands and Japan
Open Access
- 31 July 2017
- journal article
- clinical trial
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 166 (2) , 459-471
Abstract
Purpose Cultural differences are hypothesized to influence patients’ Quality of Life (QoL) reports. However, there is a lack of empirical cross-cultural studies comparing QoL of patients with cancer. This study aims to compare QoL of women with breast cancer in the Netherlands and Japan, and to investigate the association of QoL with sociodemographic, clinical, and psychological variables (illness perceptions). Methods Dutch (n = 116) and Japanese (n = 148) women with early breast cancer undergoing chemotherapy completed the EORTC QLQ-C30 and Brief Illness Perception Questionnaire immediately before their second cycle of chemotherapy. Results Dutch women reported poorer Physical, Role, Emotional, and Cognitive functioning than Japanese women. Additionally, illness perceptions were significantly different in Japan and the Netherlands, but these did not vary across treatment type. In Japan, QoL of women receiving AC-chemotherapy was better than that of women receiving FEC-chemotherapy, whereas in the Netherlands, QoL did not vary as a function of chemotherapy. Illness perceptions about symptom severity, adverse consequences, and emotional representations were negatively related to most domains of patients’ QoL in both countries. Adding illness perceptions as covariates to the ANOVA analyses rendered the effects of country and treatment type on QoL non-significant. Conclusions Comparing Dutch and Japanese women with early breast cancer revealed important differences in treatment modalities and illness perceptions which both appear to influence QoL. Perceptions about cancer have been found to vary across cultures, and our study suggests that these perceptions should be considered when performing cross-cultural studies focusing on patient-reported outcomes.Keywords
Funding Information
- Pink Ribbon, The Netherlands
- Pfizer Japan
This publication has 33 references indexed in Scilit:
- Psychological morbidity and quality of life of ethnic minority patients with cancer: a systematic review and meta-analysisThe Lancet Oncology, 2011
- Quality-of-Life Measurement in Randomized Clinical Trials in Breast Cancer: An Updated Systematic Review (2001–2009)JNCI: Journal of the National Cancer Institute, 2011
- The role of illness representations in coping and health of patients treated for breast cancerPsycho-Oncology, 2008
- Health-related quality of life in breast cancer: A cross-cultural survey of German, Japanese, and South Korean patientsBreast Cancer Research and Treatment, 2006
- Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimenAnnals of Oncology, 2006
- The Role of Illness Beliefs, Treatment Beliefs, and Perceived Severity of Symptoms in Explaining Distress in Cancer Patients During Chemotherapy TreatmentBehavioral Medicine, 2006
- Brief report: etiological attributions for breast cancer among healthy African American and European American womenPsycho-Oncology, 2005
- Culture, dialectics, and reasoning about contradiction.American Psychologist, 1999
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993
- Measurement in Cross-Cultural PsychologyJournal of Cross-Cultural Psychology, 1985